Release Date: 10/09/12 16:32 Summary: TriAusMin Revised Rights Offer Document Price Sensitive: No Download Document 272.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%